Varro Zoltan, Locklin Julia K, Wood Bradford J
Warren G. Magnuson Clinical Center, Diagnostic Radiology Department, National Institutes of Health, Building 10, Room 1C660, Bethesda, MD 20892, USA.
Cardiovasc Intervent Radiol. 2004 Sep-Oct;27(5):512-5. doi: 10.1007/s00270-003-4033-7. Epub 2004 Jun 3.
A 45-year-old male with renal cell carcinoma secondary to von-Hippel Lindau (VHL) disease presented for radiofrequency ablation (RFA) of kidney tumors. Due to his prior history of several partial nephrectomies and limited renal reserve, RFA was chosen because of its relatively nephron-sparing nature. A laser guidance device was used to help guide probe placement in an attempt to reduce procedure time and improve targeting accuracy. The device was successful at guiding needle placement, as both tumors were located with a single pass. Follow-up CT scan confirmed accurate needle placement, showing an area of coagulation necrosis covering the previously seen tumor.
一名45岁患有因冯-希佩尔-林道(VHL)病继发肾细胞癌的男性患者前来接受肾脏肿瘤的射频消融(RFA)治疗。由于他既往有多次部分肾切除术病史且肾储备有限,选择RFA是因其相对具有保留肾单位的特性。使用了一种激光引导装置来辅助引导探头放置,以期减少手术时间并提高靶向准确性。该装置成功引导了针的放置,因为两次穿刺就定位到了两个肿瘤。后续的CT扫描证实针放置准确,显示出一个覆盖先前所见肿瘤的凝固性坏死区域。